TAVR Embolic Protection Market to Reach $405.4 Million, Globally, by 2032 at 14% CAGR: Allied Market Research

Reduction in mortality rate using TAVR embolic protection devices, technological advancements in TAVR embolic protection devices, and rise in adoption of minimally invasive procedures drive the growth of the global TAVR embolic protection market.

PORTLAND, Ore., Nov. 10, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “TAVR Embolic Protection Market by Product (SENTINEL cerebral protection system, TriGUARD 3 CEP device technology): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global TAVR embolic protection market was valued for $108.7 million in 2022 and is estimated to reach $405.4 million by 2032, exhibiting a CAGR of 14% from 2023 to 2032.

Request Sample of the Report on TAVR Embolic Protection Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/74889

Prime determinants of growth

Growth in R&D activities; rise in prevalence of cardiovascular diseases, including aortic stenosis; and rise in awareness regarding use of TAVR embolic protection devices to minimize the complications are the factors that drive the growth of the global TAVR embolic protection market. However, time consuming approvals hinder the market growth. On the contrary, expansion of the healthcare sector is expected to offer lucrative opportunities for the TAVR embolic protection market during the forecast period.

Report coverage & details:

Report Coverage	Details
Forecast Period	2023–2032
Base Year	2022
Market Size in 2022	$108.7 million
Market Size in 2032	$405.4 million
CAGR	14 %
No. of Pages in Report	140
Segments covered	Product type and region
Drivers	Reduction in mortality rate Technological advancements in TAVR embolic protection devices Rise in adoption of minimally invasive procedures
Opportunities	Growing focus on R&D
Restraints	Product failure and recalls Procedural Complexity

Economic Downturn Analysis: Impact of Recession in 2023 on the TAVR Embolic Protection Market

During the recession, the demand for medical devices, such as TAVR embolic protection devices, remains stable.
As there is rise in aging population, prevailing cardiovascular diseases, including aortic stenosis; growth in investments in advanced technologies, and the ongoing clinical trials are anticipated to drive the market growth.

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/74889

The SENTINEL Cerebral Protection System segment maintained its lead position during the forecast period.

Based on product type, the SENTINEL cerebral protection system segment accounted for the largest share in 2022, accounting for more than 90% of the global TAVR embolic protection market revenue. The SENTINEL system is one of the pioneering and well-established brands in the TAVR embolic protection market. Its reputation for safety and efficacy has garnered trust among healthcare providers. Moreover, it is the only FDA and CE approved device in the market. However, TriGUARD 3 CEP device technology segment is projected to register highest CAGR of 15.2% during the forecast period owing to its innovative technology, clinical efficacy, expanded indications, and physician preference.  

North America to maintain its dominance by 2032

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for almost half of the global TAVR embolic protection market revenue, owing to factors such as sedentary lifestyle, unhealthy eating habits, and rise in geriatric population. In addition, surge in demand for minimally invasive procedures such as TAVR and availability of skilled professionals & advanced embolic protection devices technologies have made it possible to perform more complex procedures with higher success rates, leading to increase in demand for TAVR embolic protection devices in North America.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/74889

However, Asia-Pacific is expected to witness the highest CAGR of 15.1% from 2023 to 2032, owing to surge in demand for minimally invasive procedures to address the unmet needs of a large population. In addition, the development of healthcare infrastructure, rise in healthcare reforms, and increase in healthcare expenditure in emerging economies are anticipated to contribute toward the growth of the TAVR embolic protection market in Asia-Pacific.

Leading Market Players: –

Boston Scientific Corporation
Edward Lifesciences Corporation
Filterlex Medical Ltd.
Protembis Gmbh
Innovative Cardiovascular Solutions, LLC.
Encompass Technologies, Inc.
Transverse Medical Inc.
Emboline, Inc.
Cardioptimus
Venus Medtech Hangzhou Inc.

The report provides a detailed analysis of these key players of the global TAVR embolic protection market. These players have adopted different strategies such as product approval, clinical trials, & funding to increase their market share and maintain dominant position in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Comprehensive Healthcare Industry Research Studies:

Diabetes Care Devices Market – Opportunity Analysis and Industry Forecast, 2022–2032

Glaucoma Surgery Devices Market- Opportunity Analysis and Industry Forecast, 2022–2032

Gynecological Cancer Drugs Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Electrocardiograph (ECG) Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Surgical Scissors Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int’l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

[email protected]

Web: https://www.alliedmarketresearch.com

Follow Us on: LinkedIn